FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055083 [Registered on: 11/07/2023] Trial Registered Prospectively
Last Modified On: 10/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Management of Pandu (Iron Deficiency Anemia) through Ayurveda.  
Scientific Title of Study   A Comparative Study To Evaluate The Efficacy Of Ashtaguna Manda And Punarnava Mandura In The Management Of Raktalpata W.S.R. To Pandu ( Iron Deficiency Anemia). 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sheetal S Mahadik 
Designation  Associate Professor 
Affiliation  Shri Krishna Government Ayurvedic College and Hospital,Kurukshetra 
Address  Room No. 63,Department of Swasthavritta and Yoga , Shri Krishna Government Ayurvedic College and Hospital,Kurukshetra

Kurukshetra
HARYANA
136118
India 
Phone  9468475757  
Fax    
Email  shitalsingla@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sheetal S Mahadik 
Designation  Associate Professor 
Affiliation  Shri Krishna Government Ayurvedic College and Hospital,Kurukshetra 
Address  Room No. 63,Department of Swasthavritta and Yoga , Shri Krishna Government Ayurvedic College and Hospital,Kurukshetra


HARYANA
136118
India 
Phone  9468475757  
Fax    
Email  shitalsingla@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sheetal S Mahadik 
Designation  Associate Professor 
Affiliation  Shri Krishna Government Ayurvedic College and Hospital,Kurukshetra 
Address  Room No. 63,Department of Swasthavritta and Yoga , Shri Krishna Government Ayurvedic College and Hospital,Kurukshetra


HARYANA
136118
India 
Phone  9468475757  
Fax    
Email  shitalsingla@gmail.com  
 
Source of Monetary or Material Support  
Shri Krishna Government Ayurvedic College and Hospital , Kurukshetra 
 
Primary Sponsor  
Name  Dr Prateek Khatana 
Address  OPD No 2,Swasthavritta and Yoga , Shri Krishna Government Ayurvedic College and Hospital,Kurukshetra 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prateek Khatana  Shri Krishna Government Ayurvedic College and Hospital  OPD No.2, Swasthavritta and Yoga ,Shri Krishna Government Ayurvedic College and Hospital,Kurukshetra Pin 136118
Kurukshetra
HARYANA 
7009701562

prateek.khatana100@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D509||Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Ashtaguna Manda, Reference: Sharangdhar samhita, Madhyama khanda , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -Ashtaguna Manda -Ahara Kalpana
2Comparator ArmDrugClassical(1) Medicine Name: Punarnava Mandura, Reference: Charka Samhita, Chikitsa Sthana 16, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Patients between the 18 to 50 years of age.
2.Patients fulfilling the diagnostic criteria of Iron Deficiency Anemia will be selected irrespective of cast religion and profession.
3.Patients with hemoglobin level between 7 to 10 gm%.
 
 
ExclusionCriteria 
Details  1.Patients having age below 18 years and more than 50 yrs.
2.Patients having Thalassemia , Sickle cell Anemia , Leukamia and Aplastic or Hypoplastic Anemia.
3.Patient with bleeding piles.
4.Patient with chronic systematic illness( cardiac disease, cirrhosis of liver, diabetes mellitus , chronic kidney diseases, hypertension).
5.Pregnant and lactating women.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To Evaluate The Efficacy Of Ashtaguna Manda And Punarnava Mandura In The Management Of Raktalpata W.S.R. To Pandu ( Iron Deficiency Anemia).
2.Change in Subjective & Objective Parameters in Pandu  
66 Days.
Follow up will be done 0n 7th day, 14th day, 21st day. 
 
Secondary Outcome  
Outcome  TimePoints 
1 To Study Pandu from various ayurvedic texts.
2 Correlation Of Raktalpata w.s.r.Pandu (Iron Deficiency Anemia)  
66 Days.
Follow up will be done on 7th day,14th day & 21st day. 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   26/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
According to the World Health Organization (WHO), there are two billion people with anemia in the world and half of the anemia is due to iron deficiency. Anemia is a late indicator of iron deficiency, so it is estimated that the prevalence of iron deficiency is 2.5 times that of anemia. The estimated prevalence of anemia in developing countries is 39% in children <5 years, 48% in children of 5- 14 years, 42% in women of 15-59 years, 30% in men 15-59 years, and 45% in adults >60 years. These staggering figures have important economic and health consequences for low- and middle- income countries. Anaemia and iron deficiency lead to substantial physical productivity losses in  adults. The nearest correlation of iron deficiency anemia (IDA) can be made with Pandu in Ayurveda considering its main Lakshana which is Raktalpata. 

Iron preparation provides satisfactory result in iron deficiency Anemia like ferrous sulfate, ferrous gluconate, fumarate and ferric hydroxide. They often leave metallic taste in mouth. Usually, these preparations are gastric irritant and have common side effects like nausea, abdominal pain and either constipation or diarrhea. To avoid these side effects and to fulfill the above needs, this clinical study for the efficacy of Ashtaguna Manda and Punarnava Mandura is designed. Ayurveda is a health science which treats diseases by both medicines and diet (Aushadh and Aahar). Just like medicines, diet is also used for treating disease and maintaining health. Food items which are used for treatment in Ayurveda are named as Pathya Kalpana.

 
 
Close